These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 1835747

  • 21. Generation of cytolytic activity with anti-CD3 monoclonal antibodies involves both IL-2-independent and -dependent components.
    Stohl W, Tovar Z, Talal N.
    J Immunol; 1990 May 15; 144(10):3718-25. PubMed ID: 2139672
    [Abstract] [Full Text] [Related]

  • 22. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
    Moiré N, Calvo CF, Métivier D, Perrot JY, Vaquero C, Hatakeyama M, Senik A.
    Eur J Immunol; 1990 Sep 15; 20(9):1981-7. PubMed ID: 2145171
    [Abstract] [Full Text] [Related]

  • 23. Differential CD3/T cell antigen receptor-mediated IL-2 production in jurkat T cells. Dissociation of IL-2 response from total inositol phosphate and calcium responses.
    Stohl W, Hofman FM, Gray JD.
    J Immunol; 1990 Aug 15; 145(4):1078-87. PubMed ID: 2143206
    [Abstract] [Full Text] [Related]

  • 24. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T, Nakamura Y, Takeuchi Y, Tokuda Y, Iwasawa M, Kawasaki A, Okumura K, Habu S.
    J Immunol; 1992 Jan 01; 148(1):285-91. PubMed ID: 1345787
    [Abstract] [Full Text] [Related]

  • 25. Growth factor production and requirements during the proliferative response of human T lymphocytes to anti-CD3 monoclonal antibody.
    Granelli-Piperno A, Keane M, Steinman RM.
    J Immunol; 1989 Jun 15; 142(12):4138-43. PubMed ID: 2524526
    [Abstract] [Full Text] [Related]

  • 26. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y, Suzuki Y, Katakura R, Miyagi T, Yamaguchi T, Yoshimoto T, Ebina T.
    Clin Cancer Res; 1997 Apr 15; 3(4):633-43. PubMed ID: 9815731
    [Abstract] [Full Text] [Related]

  • 27. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J, Vandenberghe P, Wallays G, de Boer M, Anthony N, Panayi GS, Ceuppens JL.
    J Immunol; 1993 Feb 01; 150(3):835-46. PubMed ID: 7678624
    [Abstract] [Full Text] [Related]

  • 28. Regulation of CD3- lymphocyte function with an antibody against the IL-2 beta chain receptor: modulation of NK and LAK activity and production of IFN gamma.
    Ortaldo JR, Frey J, Takeshita T, Sugamura K.
    Eur Cytokine Netw; 1990 Feb 01; 1(1):27-34. PubMed ID: 2151685
    [Abstract] [Full Text] [Related]

  • 29. Immunodeficiency in ESRD-patients is linked to altered IL-2 receptor density on T cell subsets.
    Stachowski J, Pollok M, Burrichter H, Baldamus CA.
    J Clin Lab Immunol; 1991 Apr 01; 34(4):171-7. PubMed ID: 1668284
    [Abstract] [Full Text] [Related]

  • 30. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
    Hirsch R, Archibald J, Gress RE.
    J Immunol; 1991 Oct 01; 147(7):2088-93. PubMed ID: 1833451
    [Abstract] [Full Text] [Related]

  • 31. Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. Induction of human B cell responses by fixed activated T cells.
    Tohma S, Lipsky PE.
    J Immunol; 1991 Apr 15; 146(8):2544-52. PubMed ID: 1707911
    [Abstract] [Full Text] [Related]

  • 32. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines.
    Pimentel-Muiños FX, Muñoz-Fernández MA, Fresno M.
    J Immunol; 1994 Jun 15; 152(12):5714-22. PubMed ID: 8207202
    [Abstract] [Full Text] [Related]

  • 33. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
    Levitt LJ, Nagler A, Lee F, Abrams J, Shatsky M, Thompson D.
    J Clin Invest; 1991 Jul 15; 88(1):67-75. PubMed ID: 1676038
    [Abstract] [Full Text] [Related]

  • 34. Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells.
    Rincón M, Tugores A, López-Rivas A, Silva A, Alonso M, De Landázuri MO, López-Botet M.
    Eur J Immunol; 1988 Nov 15; 18(11):1791-6. PubMed ID: 2849551
    [Abstract] [Full Text] [Related]

  • 35. Blockade of physiologically secreted IFN-gamma inhibits human T lymphocyte and natural killer cell activation.
    Novelli F, Giovarelli M, Reber-Liske R, Virgallita G, Garotta G, Forni G.
    J Immunol; 1991 Aug 15; 147(4):1445-52. PubMed ID: 1831225
    [Abstract] [Full Text] [Related]

  • 36. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
    Yssel H, Aubry JP, de Waal Malefijt R, de Vries JE, Spits H.
    J Immunol; 1987 Nov 01; 139(9):2850-5. PubMed ID: 2444643
    [Abstract] [Full Text] [Related]

  • 37. Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts.
    Pizzolo G, Rigo A, Zanotti R, Vinante F, Vincenzi C, Cassatella M, Carra G, Castaman G, Chilosi M, Semenzato G.
    Leukemia; 1993 Mar 01; 7(3):418-25. PubMed ID: 8445947
    [Abstract] [Full Text] [Related]

  • 38. Down-regulation of KOLT-2 antigen (CD28) by interleukin 2; role of IL-2R (p70).
    Shindo T, Sugie K, Nakamura K, Tagaya Y, Maeda M, Uchiyama T, Sagawa K, Yokoyama M, Wada H, Hitomi S.
    Immunology; 1990 Sep 01; 71(1):63-9. PubMed ID: 2170270
    [Abstract] [Full Text] [Related]

  • 39. Role of LFA-1/ICAM-1 in interleukin-2-stimulated lymphocyte proliferation.
    Vyth-Dreese FA, Dellemijn TA, Frijhoff A, van Kooyk Y, Figdor CG.
    Eur J Immunol; 1993 Dec 01; 23(12):3292-9. PubMed ID: 7903074
    [Abstract] [Full Text] [Related]

  • 40. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
    Zipris D, Lazarus AH, Crow AR, Hadzija M, Delovitch TL.
    J Immunol; 1991 Jun 01; 146(11):3763-71. PubMed ID: 1827815
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.